Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
01 1AMOXICILLIN
02 9AMOXICILLIN AND CLAVULANATE POTASSIUM
03 1AUGMENTIN 125
04 1AUGMENTIN 200
05 1AUGMENTIN 250
06 1AUGMENTIN 400
07 1AUGMENTIN ES-600
08 1CEFPODOXIME PROXETIL
09 5CEFPROZIL
10 1CEFTIN
11 1CELLCEPT
12 2MYCOPHENOLATE MOFETIL
13 2SUPRAX
01 250575
02 150672
03 250725
04 150755
05 150759
06 162927
07 165066
08 165089
09 165162
10 165191
11 165236
12 165257
13 165261
14 165284
15 165355
16 165373
17 165381
18 165420
19 190031
20 1201090
21 1201091
22 1202091
23 1209371
24 1212634
25 1213955
01 26No
02 1Yes
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Drug : MYCOPHENOLATE MOFETIL
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 212634
Country : US
Patented : No
AMOXICILLIN; CLAVULANATE POTASSIUM
Drug : AMOXICILLIN AND CLAVULANATE POTASSIUM
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 209371
Country : US
Patented : No
AMOXICILLIN; CLAVULANATE POTASSIUM
Drug : AMOXICILLIN AND CLAVULANATE POTASSIUM
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 201091
Country : US
Patented : No
AMOXICILLIN; CLAVULANATE POTASSIUM
Drug : AMOXICILLIN AND CLAVULANATE POTASSIUM
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 201090
Country : US
Patented : No
Drug : CEFPROZIL
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 65381
Country : US
Patented : No
Drug : CEFPODOXIME PROXETIL
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 90031
Country : US
Patented : No
Drug : CEFPROZIL
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 65236
Country : US
Patented : No
Drug : CELLCEPT
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 50759
Country : US
Patented : No
Drug : MYCOPHENOLATE MOFETIL
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 213955
Country : US
Patented : No
Drug : AMOXICILLIN
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 62927
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
